Another Successful Learning Event Sponsored by Deltex

Nigel Keen, Chairman of Deltex Medical, commented: “The successful £2,050,000 fund raising in February 2018 has put the Group in a stronger financial position – allowing us to improve our business structure. “We made a number

Deltex Medical Group plc (LON:DEMG), the global leader in Oesophageal Doppler Monitoring, the Group’s Chairman, Nigel Keen, will make the following statement at the Annual General Meeting: Hospitals in the developed world are facing increasing pressure

Deltex Medical Group plc (LON:DEMG), the global leader in Oesophageal Doppler Monitoring, announced today that Ewan Phillips has resigned as Chief Executive and as a Director of the Company with immediate effect. Mr. Phillips recently approached Deltex’s

Deltex Medical Group plc (LON:DEMG), the global leader in Oesophageal Doppler Monitoring, today gives notice that its Annual Report and Accounts for the year ended 31 December 2017 has been published on the “Annual & Interim Reports”

Nigel Keen, Chairman of Deltex Medical, commented: “The progress made towards operating cash breakeven and profitability through improved consumable margins and reduced overheads made during 2017 was partially offset by a disappointing second half sales performance.

It takes a plethora of products and people to provide patients premium protection. Changing payment models, the digitization of healthcare and the need to deliver higher quality care at a lower cost are driving significant change